Carr Douglas sold $544 of IPSC
Carr Douglas (SVP Finance & Operations) sold 275 shares of Century Therapeutics, Inc. (IPSC) at $1.98 on 2026-08-03.
How this was made
The 30-second read
Why it matters
An officer-level open-market sale was reported without a stated 10b5-1 plan; however, the dollar value is modest and does not include any company performance or guidance change.
Market read
Traders may briefly monitor for sentiment around insider selling, but the filing lacks new fundamental catalysts.
What to watch
The filing notes no pre-arranged 10b5-1 plan, which can increase interpretive sensitivity, but the article provides no additional context (e.g., tax, planned spending, or other concurrent transactions).
Background
This is an SEC Form 4 insider transaction disclosure for Century Therapeutics, Inc. (IPSC).
Ticker impact
Century Therapeutics (IPSC) disclosed an SVP Finance & Operations open-market sale of 275 shares at $1.9770 on 2026-08-03.
Low likelihood of a sustained price move; any reaction is likely limited to short-term sentiment around insider selling.
Form 4 shows a direct open-market sale (code S) totaling about $543.68, with holdings after transaction at 504,819 shares. No new operational, regulatory, or financial guidance is provided.
Market effects
No sector-level implications; this is an issuer-specific insider transaction.
None indicated.
None indicated.
Counterpoint
Because the sale is small relative to post-transaction holdings, it may reflect diversification or liquidity needs rather than negative expectations.
Key entities
- issuerCentury Therapeutics, Inc.
Subject of the Form 4 insider transaction disclosure.
- insiderCarr Douglas
SVP Finance & Operations who sold 275 shares.
